CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation

Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection

(2013) Daniel Bremell et al.   BMC Neurology

Comparison of sampling methods for the detection of human rhinovirus RNA

(2013) Matti Waris et al.   JOURNAL OF CLINICAL VIROLOGY

Cerebrospinal Fluid Neopterin Analysis in Neuropediatric Patients: Establishment of a New Cut Off-Value for the Identification of Inflammatory-Immune Mediated Processes

(2013) Marta Molero-Luis et al.   PLoS One

Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children

(2013) Heidi Sillanpää et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Neopterin Is a Cerebrospinal Fluid Marker for Treatment Outcome Evaluation in Patients Affected by Trypanosoma brucei gambiense Sleeping Sickness

(2013) Natalia Tiberti et al.   PLoS Neglected Tropical Diseases

CXCL13 may improve diagnosis in early neuroborreliosis with atypical laboratory findings

(2012) Johannes P Borde et al.   BMC INFECTIOUS DISEASES

Evaluation of multiplex polymerase chain reaction and microarray-based assay for rapid herpesvirus diagnostics

(2012) Laura Mannonen et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Cerebrospinal Fluid Neopterin as Marker of the Meningo-Encephalitic Stage of Trypanosoma brucei gambiense Sleeping Sickness

(2012) Natalia Tiberti et al.   PLoS One

CXCL13 chemokine in pediatric and adult neuroborreliosis

(2011) N. Wutte et al.   ACTA NEUROLOGICA SCANDINAVICA

High sensitivity and specificity of the C6-peptide ELISA on cerebrospinal fluid in Lyme neuroborreliosis patients

(2011) N.D. van Burgel et al.   CLINICAL MICROBIOLOGY AND INFECTION

Discriminating Lyme Neuroborreliosis from Other Neuroinflammatory Diseases by Levels of CXCL13 in Cerebrospinal Fluid

(2011) N. D. van Burgel et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Lyme borreliosis

(2011) Gerold Stanek et al.   LANCET

Are high CSF levels of CXCL13 helpful for diagnosis of Lyme neuroborreliosis?

(2011) H. Tumani et al.   NEUROLOGY

A prospective study on the role of CXCL13 in Lyme neuroborreliosis

(2011) C. Schmidt et al.   NEUROLOGY

Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis

(2010) Ivar Tjernberg et al.   JOURNAL OF INFECTION

Lymphoid chemokines in the CNS

(2010) Stephen J. Lalor et al.   JOURNAL OF NEUROIMMUNOLOGY

Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection

(2010) Lars Hagberg et al.   AIDS Research and Therapy

Lyme borreliosis: a European perspective on diagnosis and clinical management

(2009) Gerold Stanek et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Cerebrospinal fluid neopterin in paediatric neurology: a marker of active central nervous system inflammation

(2009) RUSSELL C DALE et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis

(2009) Å. Mygland et al.   EUROPEAN JOURNAL OF NEUROLOGY

The chemokine CXCL13 in acute neuroborreliosis

(2009) M. Senel et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Increased CXCL-13 levels in human African trypanosomiasis meningo-encephalitis

(2009) Bertrand Courtioux et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

CSF B – lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis

(2008) U. Ljøstad et al.   JOURNAL OF NEUROLOGY

Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial

(2008) Unn Ljøstad et al.   LANCET NEUROLOGY